Cargando…
Creatine Kinase MB Isoenzyme Is a Complementary Biomarker in Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is an invariably fatal neurodegenerative disease with limited therapeutic options. There is an urgent need for novel biomarkers to be used as surrogates for new therapeutic trials and disease monitoring. In this study, we sought to systematically study creatine ki...
Autores principales: | Kittipeerapat, Natsinee, Fabian, Rachel, Bernsen, Sarah, Weydt, Patrick, Castro-Gomez, Sergio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380590/ https://www.ncbi.nlm.nih.gov/pubmed/37511443 http://dx.doi.org/10.3390/ijms241411682 |
Ejemplares similares
-
Creatine Kinase and Progression Rate in Amyotrophic Lateral Sclerosis
por: Ceccanti, Marco, et al.
Publicado: (2020) -
Serum Creatine Kinase-MB Isoenzyme Activity among Subjects with Uncomplicated Essential Hypertension: Any Sex Differences
por: Emokpae, Mathias Abiodun, et al.
Publicado: (2017) -
Dissimilarity in the Folding of Human Cytosolic Creatine Kinase Isoenzymes
por: Wang, Yin, et al.
Publicado: (2011) -
Correlation of Creatine Kinase Levels with Clinical Features and Survival in Amyotrophic Lateral Sclerosis
por: Tai, Hongfei, et al.
Publicado: (2017) -
Interrelationship of rotavirus infection and Creatine Kinase-MB isoenzyme levels in children hospitalized with acute gastroenteritis in Guangzhou, China, 2012–2015
por: Zheng, Jianbin, et al.
Publicado: (2017)